Zdrowie i gospodarka · 09/09/2019

FDA Clears Path for CALCIMAR (calcitonin salmon) Injection, 200 IU/mL

The Food and Drug Administration (FDA) has determined that CALCIMAR (calcitonin salmon) Injection, 200 IU/mL, was not withdrawn from sale due to safety or effectiveness concerns. This decision enables the FDA to approve abbreviated new drug applications (ANDAs) for CALCIMAR (calcitonin salmon) Injection, 200 IU/mL, provided all other regulatory requirements are fulfilled.